WCM INVESTMENT MANAGEMENT, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 159 filers reported holding REATA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.

Quarter-by-quarter ownership
WCM INVESTMENT MANAGEMENT, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,716,000
-27.8%
26,997
+1.6%
0.01%
-40.0%
Q2 2021$3,761,000
-7.9%
26,576
-35.1%
0.01%
-9.1%
Q1 2021$4,084,000
+25.5%
40,959
+55.7%
0.01%
+22.2%
Q4 2020$3,253,000
+27.5%
26,312
+0.4%
0.01%0.0%
Q3 2020$2,552,000
-33.7%
26,196
+6.3%
0.01%
-40.0%
Q2 2020$3,847,000
+124.3%
24,655
+107.5%
0.02%
+66.7%
Q1 2020$1,715,000
-0.3%
11,882
+41.1%
0.01%0.0%
Q4 2019$1,721,000
+239.4%
8,419
+33.4%
0.01%
+200.0%
Q3 2019$507,000
-36.9%
6,309
-26.0%
0.00%
-40.0%
Q2 2019$804,000
+6.9%
8,529
-3.1%
0.01%0.0%
Q1 2019$752,0008,8020.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders